Pfizer submits COVID-19 vaccine trial data to FDA for children aged 5-11

Pfizer submits COVID-19 vaccine trial data to FDA for children aged 5-11 – CBS News

Watch CBSN Live


Pfizer and BioNTech announced they have submitted results to the U.S. Food and Drug Administration from their coronavirus vaccine trial on children aged 5 to 11. According to a statement, the results showed a “favorable safety profile.” Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, joined CBSN to discuss.

View CBS News In

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.